Search results
Jul 22, 2021 · Results suggest the discrepancy between expected and observed weight loss with SGLT2 inhibitors cannot be explained by increases in appetite or changes in appetite-regulating hormones. Further studies are needed to investigate alternative metabolic compensatory mechanisms to optimize weight loss with SGLT2 inhibitor use.
Scope: Obesity is a common disease worldwide and there is an urgent need for strategies to preventing obesity. Methods and results: The anti-obesity effect and mechanism of Ligilactobacillus salivarius LCK11 (LCK11) is studied using a C57BL/6J male mouse model in which obesity is induced by a high-fat diet (HFD).
Jan 6, 2024 · The following foods (or major bioactive components) have been found to inhibit aromatase or to enhance the effectiveness of aromatase inhibitors and are recommended during treatment: Artic char. Artichokes. Arugula. Beans, dry. Bell peppers. Blackberries. Blueberries & bilberries. Boysenberries.
SGLT2 inhibitors are glucose-dependent and can excrete approximately 60-100 g of glucose per day in the urine . Despite the calorie loss effects of SGLT2 Inhibitors, it causes less weight loss than expected due to an adaptive increase in energy intake, including compensatory increases in appetite/caloric intake .
Monoamine reuptake inhibitors, including DRIs, have shown effectiveness as therapy for excessive food intake and appetite control for obese patients. Though such pharmacotherapy is still available, the majority of stimulant anorectics marketed for this purpose have been withdrawn or discontinued due to adverse side effects such as hypertension ...
Feb 1, 2005 · Sibutramine, a norepinephrine–5-hydroxytryptamine reuptake inhibitor, is approved for long-term use. Several new mechanisms for drug action are under investigation. Appetite suppressants should ...
Jun 26, 2023 · Phosphodiesterase inhibitors (PDE inhibitors) are a class of agents acting on phosphodiesterase enzymes. They are FDA approved to manage chronic obstructive pulmonary disease, erectile dysfunction, pulmonary arterial hypertension, acute decompensated heart failure, psoriasis, psoriatic arthritis, atopic dermatitis, and neonatal apnea.
